Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Blood|January 24, 2023
How I treat multiple myeloma in geriatric patientsThierry Facon, Xavier Leleu, Salomon Manier
Blood|August 15, 2002
Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapyPhilippe Moreau, Thierry Facon, Xavier Leleu, et al.
Blood|October 25, 2003
Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patientsMarc André, Nicolas Mounier, Xavier Leleu, et al.
Blood|August 21, 2010
Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation studyPhilippe Moreau, Arnaud Jaccard, Lotfi Benboubker, et al.
Blood|September 6, 2013
Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN)Meletios A Dimopoulos, Ramón García-Sanz, Maria Gavriatopoulou, et al.
Blood|November 23, 2016
BDR in newly diagnosed patients with WM: final analysis of a phase 2 study after a minimum follow-up of 6 yearsMaria Gavriatopoulou, Ramón García-Sanz, Efstathios Kastritis, et al.
Blood|May 2, 2008
SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemiaHai T Ngo, Xavier Leleu, Jack Lee, et al.
Blood|February 23, 2024
Daratumumab, carfilzomib, lenalidomide, and dexamethasone with tandem transplant for high-risk newly diagnosed myelomaCyrille Touzeau, Aurore Perrot, Cyrille Hulin, et al.
Blood|March 19, 2015
Phase 1/2 study of carfilzomib plus melphalan and prednisone in patients aged over 65 years with newly diagnosed multiple myelomaPhilippe Moreau, Brigitte Kolb, Michel Attal, et al.
Blood|March 28, 2013
MYD88 L265P mutation in Waldenstrom macroglobulinemiaStéphanie Poulain, Christophe Roumier, Audrey Decambron, et al.
Pageof 5